NovaBridge Biosciences
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $878.9M
Liabilities Breakdown FY2021
Total Liabilities: $163.5M
Asset Breakdown
Total Assets: $878.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $552.9M | 62.9% |
| Accounts Receivable | $5.2M | 0.6% |
| Inventory | $4.3M | 0.5% |
| Property, Plant & Equipment | $7.2M | 0.8% |
| Goodwill | $25.5M | 2.9% |
| Intangible Assets | $18.8M | 2.1% |
| Other Assets | $265.1M | 30.2% |
Liabilities Breakdown
Total Liabilities: $163.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $93.1M | 57.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $70.3M | 43.0% |